STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
74 hedge funds and large institutions have $104M invested in Stemline Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 69 → 74 (+5)
Holders
74
Holding in Top 10
–
Calls
$690K
Puts
$344K
Top Buyers
| 1 | +$2.78M | |
| 2 | +$2.75M | |
| 3 | +$2.14M | |
| 4 |
Millennium Management
New York
|
+$1.22M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$1.01M |
Top Sellers
| 1 | -$4.13M | |
| 2 | -$2.07M | |
| 3 | -$852K | |
| 4 |
CCI
Columbus Circle Investors
|
-$513K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$400K |